(Q41351656)

29 September 2017

Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations (English)

1 reference

29 September 2017

1 reference

1 reference

2

U K Rinne

1 reference

29 September 2017

H M Ruottinen

1

1 reference

PMCID

486187

29 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

29 September 2017

1 reference

29 September 2017

60

1 reference

29 September 2017

1

1 reference

29 September 2017

36-40

1 reference

Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486187

Parkinsonism: onset, progression, and mortality

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486187

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486187

The metabolism of L-3-0-methyldopa, aprecursor of dopa in man

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486187

Simultaneous determination of levodopa, its main metabolites and carbidopa in plasma by liquid chromatography

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486187

Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486187

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486187

Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patients

11 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8558148

12 December 2020

inferred from PubMed ID database lookup

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8558148

12 December 2020

inferred from PubMed ID database lookup

[The L-dopa test in Parkinson's disease]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8558148

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/JNNP.60.1.36

1 reference

release_odzmdfbgxjeb5cypfl2wtnmmgi

29 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/odzmdfbgxjeb5cypfl2wtnmmgi

24 November 2022

mapped directly with Wikidata item

PMCID

486187

1 reference

29 September 2017

1 reference

PMCID

486187